Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09RJA
|
|||
| Former ID |
DNCL003791
|
|||
| Drug Name |
RELVARTM or BREOTM ELLIPTATM
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8] | NDA filed | [1] | |
| Company |
Theravance
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | RELVAR ELLIPTA receives regulatory approval in Japan. Theravance. 24 September 2013. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.